Clinical Trial Update: Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating liposome bupivacaine for femoral nerve block to manage postoperative pain after total knee arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain
• Total Knee Arthroplasty

Drugs mentioned

• liposome bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-12-09